27.8.2019
•
News
M&A
KŠB Advises Karlovarské minerální vody on Acquisition of Largest Serbian Mineral Water Producer
KŠB’s team led by partners Dagmar Dubecká and Martin Krejčí with associates Ivo Průša and Jana Guričová advised Karlovarské minerální vody Group (KMV), which, in a joint venture with PepsiCo, acquired Knjaz Miloš – the largest Serbian mineral water and non-alcoholic beverage producer.
We advised primarily on the financing of the entire acquisition (both at the level of KMV’s and PepsiCo’s joint venture and at the level of KMV), on the conclusion of a shareholder agreement, and on setting the mutual relationships between KMV and PepsiCo.
The parties have not disclosed the value of the transaction, but it is one of the most expensive acquisitions for the KMV Group.
For more information, click here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
